Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting more from semaglutide treatment comes down to a handful of consistent habits, not dramatic overhauls. Most people find that protein intake, sleep quality, and timing of meals relative to appetite changes make the biggest practical difference. Wegovy (semaglutide) is a prescription-only medicine, meaning a prescriber has to decide whether it is right for you before treatment begins — and the choices you make once you start are just as clinically important as the medicine itself. This page draws on NHS guidance on semaglutide and the published trial data to give you a grounded, practical picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and more than many people expect. Semaglutide slows gastric emptying and raises feelings of fullness, so appetite often drops noticeably, particularly in the day or two after each weekly injection. That window is real, but it is easy to misuse it. Eating very little sounds appealing when you are not hungry, yet chronically low protein intake causes the body to shed muscle alongside fat, which lowers resting metabolic rate and makes long-term weight maintenance harder.
A practical rule endorsed by dietitians working alongside GLP-1 prescribers: prioritise protein at every meal while appetite is suppressed, even if portions are small. Eggs, fish, Greek yoghurt, legumes, and lean meat all deliver protein in compact portions that feel manageable when your stomach empties slowly. Fibre matters too, vegetables, oats, and pulses support satiety and gut health. Ultra-processed foods tend to slip past the satiety signal more easily, so the same calorie amount in crisps or biscuits is less filling than it would be in whole-food form. The evidence on Wegovy's effectiveness for weight loss consistently shows better outcomes when dietary quality goes up alongside treatment. That is not a coincidence.
Hydration deserves a mention here. Nausea is among the most common side effects, and mild dehydration makes it worse. Aiming for regular plain water through the day (rather than large volumes at once) is consistently easier on the stomach than drinking reactively.
Substantially. The STEP 1 trial, published in the New England Journal of Medicine, was conducted alongside lifestyle intervention: participants received dietary counselling and were asked to increase physical activity. The roughly 15% average weight loss seen at the 2.4mg maintenance dose in that trial is not the figure you would expect from the medicine in isolation. Activity amplifies the deficit semaglutide creates by suppressing appetite.
Resistance training is worth singling out. It is the most effective way to preserve lean muscle mass during a calorie deficit, which protects metabolic rate as weight comes down. If you have never done structured resistance work, you do not need a gym membership, bodyweight exercises at home, or resistance bands, achieve the same result. Two sessions a week is enough to make a difference. Cardiovascular activity (walking, cycling, swimming) adds to overall energy expenditure and supports heart health independently of weight loss.
Starting low is fine. Appetite suppression sometimes brings fatigue, especially early in treatment. A daily 20-minute walk is a better foundation than one intense session followed by two days recovering. Build gradually. If you want to understand whether Wegovy is effective and what the evidence actually shows, the real-world data points consistently to lifestyle engagement as one of the strongest predictors of response.
Sleep quality directly influences weight-loss outcomes through several pathways: poor sleep raises ghrelin (the hunger hormone), increases cortisol, and impairs insulin sensitivity. None of that is cancelled by semaglutide. Seven to nine hours for most adults is a consistently supported target. If sleep is disrupted by work, young children, or shift patterns, that is worth raising with your prescriber, it is clinically relevant, not a lifestyle footnote.
Chronic stress has a similar picture: elevated cortisol promotes abdominal fat storage and can blunt the appetite-suppressing effect of GLP-1 medicines. Stress management is genuinely part of optimising treatment, even if it sounds vague. Structured approaches (brief mindfulness practice, reduced screen time before bed, regular outdoor time) have reasonable evidence behind them and cost nothing.
On injection timing: consistency matters more than the specific day of the week. Choosing a day and sticking to it keeps semaglutide's steady-state level stable. Some people find that injecting on a Friday means any initial nausea lands over a weekend when the pace is slower; others prefer Monday. Pick whatever suits your week. If you miss a dose and more than five days remain before your next scheduled injection, take it as soon as you remember, if fewer than five days remain, skip to the next scheduled dose. Your prescriber and the Patient Information Leaflet are the authority on missed doses; the above is context only, not instruction.
Directly, yes. The titration pathway (starting at 0.25mg and stepping up every four weeks toward the 2.4mg maintenance dose) exists to reduce early gastrointestinal side effects, but it also reflects how the medicine establishes its effect. Trying to move through doses faster than the schedule allows typically results in more nausea and vomiting, which makes it harder to eat well and undermines the consistent lifestyle habits described above. A prescriber who reviews your progress properly at each stage is the safeguard against that.
That is where clinical oversight earns its place. A prescriber who can see your progress, your side-effect profile, and your health history will titrate appropriately, and know when a slower escalation is the right call. Skipping clinical review, whether by sourcing medicine informally or by ignoring aftercare, removes that layer and reduces effectiveness as much as any lifestyle factor. People sometimes wonder whether the 0.25mg starting dose of Wegovy is doing anything at all, which is worth reading before you start, since the 2.4mg maintenance dose is where the headline trial figures come from.
At nume, our clinical team reviews each patient's case before every repeat, not as a formality, but to catch exactly these situations. If you are curious about how effective semaglutide is across the research, that is a useful read before committing to a treatment pathway. If cost is a consideration when thinking about private treatment, a transparent breakdown of what is included matters; you can review that on the Wegovy cost page. When you are ready to discuss whether semaglutide treatment is right for you, check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.